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Abstract
Pediatric rheumatic diseases with predominant musculoskeletal involvement such as juvenile
idiopathic arthritis (JIA) and juvenile dermatomyositis(JDM) can cause considerable physical
functional impairment and significantly affect the children's quality of life (QOL). Physical function,
QOL, health-related QOL (HRQOL) and health status are personal constructs used as outcomes
to estimate the impact of these diseases and often used as proxies for each other. The chronic,
fluctuating nature of these diseases differs within and between patients, and complicates the
measurement of these outcomes. In children, their growing needs and expectations, limited use of
age-specific questionnaires, and the use of proxy respondents further influences this evaluation.
This article will briefly review the different constructs inclusive of and related to physical function,
and the scales used for measuring them. An understanding of these instruments will enable
assessment of functional outcome in clinical studies of children with rheumatic diseases, measure
the impact of the disease and treatments on their lives, and guide us in formulating appropriate
interventions.
Introduction
Pediatric rheumatic diseases causing arthritis, fatigue,
muscle weakness and blindness are associated with signif-
icant functional impairment. For several children with
rheumatic illness, physical functional ability is often the
chief determinant of their well-being. Quality of life
(QOL), health-related QOL (HRQOL), physical function
and health status scales are all used as outcome measures
in children with significant musculoskeletal involvement,
and account for varying degrees of patient-perceived state
of physical ability/and or impact of physical disability on
overall well being.
The World Health Organization QOL group defined QOL
as "individuals' perceptions of their position in life in the
context of the culture and value systems in which they live
and in relation to their goals, expectations, standards and
concerns. It is a broad ranging concept affected in a com-
plex way by the person's physical health, psychological
state, level of independence, social relationships, and
their relationships to salient features of their environ-
ment" [1]. Calman et al has presented a "goal-oriented"
model where QOL measures the difference between a per-
son's expectations and current position at a certain
time[2]. Recent scientific advances have increased life
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and commensurate drug-related complications, more fre-
quent medical visits and evaluation, all of which can lead
to significant emotional and lifestyle changes. QOL
emerges as a critical issue in this regard and becomes a pri-
mary consideration for the improvement in modern med-
icine.
Specifically for patients with chronic diseases, health pri-
marily impacts the overall QOL. HRQOL is defined as
"optimum levels of mental, physical, role and social func-
tioning, including relationships, and perceptions of
health, fitness, life satisfaction and well-being" [3].
Implicit in HRQOL is the "assessment of patient's satisfac-
tion with treatment, outcome and health status and with
future prospects" [3]. Health status usually refers to gen-
eral physical and mental health and is often weighted
towards symptoms and physical function. Sometimes,
disease-specific measures of impact on organ systems are
used to denote health status. In clinical studies, there is
considerable overlap between QOL, HRQOL and health
status. Since QOL, HRQOL, and health status are distinct
constructs measuring different patient-specific informa-
tion, all three deserve appropriate consideration in clini-
cal outcome studies [4]. Scales used for assessment of
physical function and HRQOL in pediatric rheumatic dis-
eases have been reviewed previously [5-11]. In the follow-
ing sections, we will provide an updated review of tools
used to assess physical function measures.
Pediatric rheumatic diseases comprise a heterogeneous
group of diagnoses that have different clinical features,
complications and prognosis such as juvenile idiopathic
arthritis (JIA), dermatomyositis, systemic lupus erythema-
tosus (SLE), vasculitis, and scleroderma. Physical ability is
a very relevant outcome in children with predominantly
musculoskeletal involvement such as JIA and dermatomy-
ositis [12-17]. We will briefly discuss the impairment of
physical function in JIA and dermatomyositis and in all
the other pediatric rheumatic diseases; problems encoun-
tered in measuring outcomes such as physical function
and HRQOL; and the different scales used in practice.
Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA) is a term comprising
subtypes of chronic inflammatory arthritides, causing ero-
sive arthritis in children, often progressing to disability.
These children experience functional impairment due to
joint and back pain, heel pain, swelling of joints and
morning stiffness, contractures, pain, and anterior uveitis
leading to blindness. Children with rapidly progressive
destructive synovitis, early involvement of small joints of
hands and feet, unrelenting inflammation, subcutaneous
nodules, and rheumatoid factor positivity are at signifi-
cant risk for long-term disability [18]. Many children
develop severe erosive hip disease along with other joint
involvement, resulting in contractures, joint destruction
and ankylosis, often necessitating joint replacements.
Children with long-standing disease may have significant
growth retardation including short stature and failure to
thrive.
Severe erosive disease can cause significant loss of joint
motion, an important determinant of functional disabil-
ity in children [19]. Depending upon the severity and
extent of disease involvement, children often experience
significant pain and disability, which impede the execu-
tion of ordinary activities. [20].
Oliveira et al conducted a multinational, multicenter,
cross-sectional study of patients with JIA and assessed
proxy-reported HRQOL with the Child Health Question-
naire (CHQ) and compared with that of age-matched
healthy children from the same geographic area. Over
6,000 participants were enrolled from 32 countries. The
physical and psychosocial summary scores of the CHQ
were significantly lower in children with JIA compared to
healthy children with greatest impairment in the physical
well-being domain. Patients with persistent oligoarthritis
had better HRQOL compared with other subtypes,
whereas HRQOL was similar across patients with systemic
arthritis, polyarthritis, and extended oligoarthritis. Physi-
cal wellbeing was influenced by the level of functional
impairment, and psychosocial health by the intensity of
pain [21].
Shaw et al examined HRQOL of 308 adolescents with
juvenile idiopathic arthritis (JIA) using the Juvenile Arthri-
tis Quality of Life Questionnaire (JAQQ) in UK. HRQOL
of adolescents with JIA was less than optimal, particularly
in the domains of gross motor and systemic functioning.
Items most frequently rated as adolescents' biggest psy-
chological problems were "felt frustrated" and "felt
depressed," thus confirming the widespread effects of JIA
[22].
Since JIA has such widespread impact on physical func-
tion, functional ability has been included as one of the
core set of outcome variables for the assessment of chil-
dren with JIA and these core response variables are also
valuable in defining flare in them [23,24]. Aggressive
treatment along with physical and occupational therapy
remain the keystones of managing severe disease.
Dermatomyositis
Dermatomyositis is a rare chronic inflammatory disease
causing significant weakness of the proximal muscles
associated with characteristic skin rash. Muscle involve-
ment causing motor weakness hinders children from per-
forming routine activities such as walking, getting up fromPage 2 of 11
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fever and muscle pain and weakness could worsen func-
tional status. Children with persistent inflammatory dis-
ease may exhibit diminished muscle mass due to atrophy,
calcific nodules and flexion contractions that cause sub-
stantial functional impairment. Physical function is a core
set-outcome criterion for measuring clinical outcome and
assessing clinical improvement in children with myositis
[25]. Functional ability and muscle strength assessments
were designated for both activity and damage core sets
[26].
Other rheumatic diseases and medication related 
morbidity
Other inflammatory vasculitic diseases cause functional
impairment due to fatigue, arthritis, myositis, rash, and
organ damage. In some instances these may be disfiguring
and lead to blindness, paralysis or cognitive impairment.
Children with scleroderma may experience skin tighten-
ing that is significant enough to cause contractures. In
cases of severe morphea, the involvement of the skin may
be so profound that it may involve bony tissue, possibly
leading to complete non-use of the affected limb.
In addition to the disease-related causes of functional lim-
itation, many children with the systemic lupus erythema-
tosus (SLE) suffer consequences of long-term steroid use,
such as avascular necrosis of the joints, severe osteoporo-
sis which makes bones prone to frequent fracturing,
requiring surgical joint repair and/or replacement to
improve function. Moreover, children on steroids are
prone to infection and experience delayed healing of
wounds due to their compromised immune status thus
complicating their post-operative course. Steroid-related
side-effects include obesity, cushingoid features, acne and
growth retardation leading to low self-esteem in children
that in addition to the disease-related morbidity may
reduce their motivation to participate in physical activi-
ties.
For children with rheumatic disease, functional impair-
ment encompasses physical, visual and cognitive limita-
tion, and is complicated by the psychosocial impact of
having a chronic disease. As pain and fatigue significantly
influence children's well being, these should be critical
considerations in the measurement of physical ability.
Children with pain amplification syndrome can experi-
ence severe functional limitations requiring intensive
physical therapy often combined with counseling.
Problems encountered while assessing 
outcomes in children
The heterogeneity of rheumatic diseases causing func-
tional impairment, children's changing cognitive skills,
needs and expectations, limited availability of question-
naires during the transition from childhood to adulthood,
overlap in the constructs measured by these scales, as well
as the use of proxy respondents are all factors that compli-
cate measurement of physical function, health status,
QOL and HRQOL in children [27-31]. Many instruments
modified from adult scales may not take into account a
specific phase of children's development which impacts
cognitive function, autonomy, body image, expectations,
level of independence and recall [32]. Age and language-
adjusted formats with items relevant for each age group
are ideal for the evaluation of physical function and
related outcomes in children over a broad age-range. As
most rheumatic diseases are chronic, frequently progress-
ing into adulthood, it is essential to address the lack of
instruments to measure physical function, QOL, HRQOL
and health status through this phase of growth. Appropri-
ate transitional measures can enable prospective follow-
up from childhood to adulthood and facilitate the formu-
lation of both clinically and methodologically accurate
comparisons. The Childhood Health Assessment Ques-
tionnaire (CHAQ) and the Health Assessment Question-
naire (HAQ) can be used in child and adult populations
to measure physical function and enable evaluation dur-
ing the transition process.
The level of parent-child agreement in children with
arthritis and other conditions appears to vary for disabil-
ity, pain, QOL, and HRQOL [28,33-35]. Waters et al
examined parent and adolescent agreement on physical,
emotional, mental and social health and well-being in a
representative population using the Child Health Ques-
tionnaire. Authors reported that adolescents were much
less positive about their health and well-being compared
to their parents, and were only in close agreement on
aspects of health and well-being they rated highly [36].
Greater correlation between child and parent reports has
been noted in the more objective domains such as physi-
cal function as compared to the social and emotional
domains. Brunner et al examined agreement 58 child-par-
ent dyads from Rheumatology clinics and found good
agreement for scores of the Childhood Health Assessment
Questionnaire (CHAQ), Juvenile Arthritis Quality of life
Questionnaire (JAQQ) and moderate agreement for Pedi-
atric Quality of Life inventory (PedsQL), visual analog
scale of wellbeing, and the standard gamble utilities [37].
Wagner et al explored the function of children's illness-
related cognitive assessments in the parent-child adjust-
ment relationships specific to the context of juvenile
arthritis, and found that increased parental distress and
child illness intrusiveness were related to increased
depressive symptoms in the child [38].
Palmisani et al investigated concordance between physi-
cians and parents in rating the degree of functional abilityPage 3 of 11
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cordance, parent over-rating and physician over-rating
were observed in 107 (69%), 29 (18.7%) and 19 (12.3%)
evaluations, respectively. Parent over-rating was associ-
ated with greater intensity of pain (p = 0.01) and higher
Childhood Health Assessment Questionnaire (CHAQ)
score (p = 0.004), whereas physician over-rating was asso-
ciated with more severe joint disease (p = 0.04 to <0.001),
higher C-reactive protein (p = 0.03) higher frequency of
Steinbrocker functional class = II (p < 0.001), and greater
articular damage, as measured with the Juvenile Arthritis
Damage Index (p < 0.001). Overall, the physicians and
parents revealed fair concordance in rating functional
ability of children with JIA [39].
Shaw et al found acceptable agreement for pain, general
well-being, functional disability, and HRQOL among 303
adolescents with JIA and parents Where discrepancies
occurred, parents rated functional ability worse than did
adolescents. Although proxy report is likely to be valid for
adolescents with JIA at either mild or severe end of the
spectrum and/or for the visible manifestations of the dis-
ease, there was a wide variation in agreement between
adolescents with JIA and their parents that is dependent
on the type of health-related variable [40].
These findings stress the need to explore the relationship
between the child and parent factors in child adjustment.
The level of child-parent agreement varies with child's
physical and health status, parent's physical and emo-
tional well being, domain assessed, instrument used, and
the construct measured. Obtaining child-reports in con-
junction with parent-reports and further exploratory stud-
ies will contribute to the constructive examination of the
determinants of concordance.
Other potential limitations of the functional status meas-
ures include ceiling effect, score inflation by inflammatory
pain, reversibility of functional limitations (when second-
ary to inflammation instead of true damage), non appli-
cability in younger children, lack of clinical studies to
establish all the psychometric properties, and increased
length and problems with administering them (such as
the need for skilled personnel). Further, most of these
physical function scales measure functional ability and in
some cases general health status (such as the Short Form-
36 and the Child Health Questionnaire) but cannot be
used as proxies for HRQOL or QOL. Table 1 lists the dif-
ferent scales under categories of physical function, health
status, HRQOL and QOL.
Table 1: Classification of assessment tools in pediatric rheumatology
Physical Function
1. Childhood Health Assessment Questionnaire (CHAQ)
2. Juvenile Arthritis Functional Assessment Scale (JAFAS)
3. Juvenile Arthritis Functional Assessment Report (JAFAR)
4. Juvenile Arthritis Functional Status Index (JASI)
5. Juvenile Arthritis Functionality Scale (JAFS)
6. Juvenile Arthritis Foot disability Index (JAFI)
7. Child Activity Limitations Interview (CALI)
8. Childhood Arthritis Impact Measurement Scales (CHAIMS)
9. Functional Status Measure FSII (R)
10. Steinbrocker Classification
11. Weighting of joint counts
12. Childhood Myositis Assessment Scale (CMAS)
Health Status*
1. Short-Form General Health Survey SF-36 and Short Form-20 (SF-20)
2. Child Health Questionnaire (CHQ)
3. Childhood Arthritis Health Profile (CAHP)
4. The Child Health and Illness Profile chip (CHIP)
Health-related QOL and QOL*
1. Pediatric QOL Inventory (PedsQL) – generic and rheumatology module
2. Juvenile Arthritis Quality of Life Questionnaire (JAQQ)
3. EQ5D (EuroQOL)
4. TNO AZL Children's Quality of Life questionnaire (TACQOL)
5. Quality of My Life Visual Analog Scale
6. Simple Measure of Impact of Lupus Erythematosus in Youngsters© (SMILEY©)
This table lists some of the commonly used scales used to assess physical function, health status and QOL.
*Sometimes health status, HRQOL and QOL scales are used interchangeablyPage 4 of 11
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rheumatic diseases
Pediatric studies typically use descriptive health status
scales, which explore various domains and their relation-
ship with each other, instead of utilities or preference-
based measures, which quantitatively assess individual
preferences. With utility scales, results have been variable
in case of children with musculoskeletal diseases, and
therefore the account will focus on descriptive measures
[41]. The choice of the instrument is dependent upon the
extent of the impact and type of pediatric rheumatic dis-
ease, since there are some scales that focus on measuring
the impact of physical function alone and others that
assess physical function as a part of the assessment of a
more global construct such as health status or QOL.
Although these scales are most often used in JIA, they have
a role in characterizing physical function in children with
lupus, scleroderma, and pain amplification syndromes.
Childhood Health Assessment Questionnaire (CHAQ)
The Childhood Health Assessment Questionnaire
(CHAQ), a widely used valid and reliable measure of
physical function in children with rheumatic diseases is
adapted from the Health Assessment Questionnaire
(HAQ) [17,42-44]. The HAQ, used widely in adults, takes
into account drug side effects, death and dollar costs in
addition to disability, discomfort and pain, although the
commonly used components for outcome studies are the
disability index, discomfort and pain scales. The CHAQ
consists of both child- (8–19 years) and parent-reports
(2–19 years), takes less than 10 minutes to complete, is
easy to administer, score and interpret, with main areas of
focus being disability and discomfort. The CHAQ
domains estimating disability index and the pain scales
and scoring are analogous to those in the HAQ. After 19
years of age, the HAQ can be used to assess physical func-
tion. The CHAQ does not take into account drug side
effects, death and dollar costs. The 30 items relating to dis-
ability pertain to problems or limitations in the past week
attributable to illness in the eight domains of dressing and
grooming, arising, eating, walking, hygiene, reach, grip,
and activities. The answers are in the form of a 4-point Lik-
ert scale with an additional option "not applicable." Dis-
ability index, estimated as the mean of the eight domain
scores ranges from 0–3, where zero indicates no disability
and three translates to severe disability. The score
accounts for the aids or devices used, and assistance
needed to perform the listed activities. Doubly anchored
visual analog scales evaluate Discomfort and Global
assessment [17].
When originally developed in 1994, the CHAQ was found
to have excellent psychometric properties including test-
retest reliability, convergent validity, and good correla-
tions with other scales measuring related constructs such
as the Steinbrocker's functional class, active joint count,
disease activity and degree of morning stiffness and subse-
quently has been found to be responsive [17,45]. Ruperto
et al compared the relative responsiveness of outcome
measures in 26 children with oligoarticular juvenile
chronic arthritis which included physician and parent glo-
bal assessments, functional ability as assessed by the
CHAQ, articular variables, and laboratory markers of sys-
temic inflammation. These outcomes were assessed at
admission and 3 months later. Standardized response
median, the effect size, and the Guyatt methods were used
to calculate responsiveness. The most responsive meas-
ures were the physician global assessment of disease activ-
ity, and articular variables such as the active joint count,
global articular severity score, and the number and score
of swollen joints. The parent global assessment of the
child's well being, the scores of joints with pain/tender-
ness and limited range of motion, and the number of
joints with limited range of motion displayed intermedi-
ate responsiveness. Among the least responsive measures
were the CHAQ, morning stiffness, and laboratory indica-
tors of systemic inflammation [46].
The minimal clinically important difference (MCID) has
been calculated for the CHAQ scores to follow long-term
outcomes in children with JIA [47]. Brunner et al calcu-
lated changes in CHAQ scores for patient ratings (n = 67)
between clinic visits. Changes in patient well-being, dis-
ease activity and the occurrence of flare or important
improvement between visits were used as standards for
the MCID. MCIDs were defined as the median changes of
the CHAQ scores of individual patients who had a mini-
mal important improvement or worsening between visits.
The median change in CHAQ scores of patients who rated
themselves or were rated by others as unchanged was
often 0. Depending on the external standard used, the
maximum MCID was -0.188 for improvement and
+0.125 for worsening. Authors found that the minimal
clinically important differences (MCID) of the CHAQ for
both worsening and improvement are often close to the
level of the smallest potential difference (0.125), suggest-
ing that the CHAQ may be relatively insensitive to short
term changes in children with JIA [48].
Rasch analysis was used to to compare the difficulty of
each of the 30 items for children of 2 age groups (> or =
10 years old and <10 years old). Although, 8 of the 30
items (27%) of the CHAQ were rated significantly differ-
ent in the 2 age groups, the impact on the CHAQ disabil-
ity index using its original scoring system remained low
(about 0.25 points on a scale of 0–3). CHAQ's design and
scoring system appeared to remove the bias due to differ-
ence in physical development [49].Page 5 of 11
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tional outcome in children with arthritis and has been
translated into several languages and cross-culturally
adapted in a number of countries[50]. It has been used to
measure physical function in children with SLE [51].
CHAQ is also valid, internally reliable (inter-item correla-
tion range 0.35–0.81, n = 115), and responsive (effect size
= 1.05 and standardized response mean = 1.20) in assess-
ing physical function in children with idiopathic inflam-
matory myositis and is used as an important measure of
functional outcome in clinical trials [52].
Juvenile Arthritis Functional Assessment Scale (JAFAS) and 
Juvenile Arthritis Functional Assessment Report (JAFAR)
The Juvenile Arthritis Functional Assessment Scale
(JAFAS) assesses physical function in children aged 7–16
years in clinic settings. It is a comprehensive measure of
physical function, which requires standardized equip-
ment and entails administration by a trained health pro-
fessional, physical or an occupational therapist, who
times the child's performance on 10 tasks [15]. The JAFAS
is reliable and valid, but its responsiveness has not been
established. It has been used along with the CHAQ as a
measure of functional ability in a study examining the
relationship between joint impairment and physical func-
tion [19]. The JAFAS has been used as a standard measure
of physical function in a study to evaluate the reliability
and validity of a Spanish version of the CHAQ [53].
Bekkering et al conducted a cross-sectional study in 28
children with JIA to compare the measurement properties
JAFAS with CHAQ on the level of individual items. Cron-
bach's alpha was high for both the JAFAS (0.92) and the
CHAQ (0.96). The Spearman correlation coefficient
between the JAFAS and the CHAQ was significant (0.55, p
< 0.01). With six out of ten items, the JAFAS classified the
child as less disabled than with corresponding CHAQ
activities. Overall, associations with measures of disease
activity and joint range of motion were higher for the
CHAQ than for the JAFAS [54].
The Juvenile Arthritis Functional Assessment Report
(JAFAR), a reliable and valid 23-item scale evaluating
physical functional ability has both child- and parent-
reports [16]. The responses are in the form of 3-point
scales, and total scores range from 0–46, where lower
scores indicate better function. Both these versions have
good construct validity, reliability and responsiveness
[16,55]. The JAFAR has been used in multiple clinical
studies to assess physical function in children with JIA
[38]. While measuring convergent validity of the Child-
hood Myositis Assessment Scales (CMAS), JAFAR was one
of the standard measures of physical function [56]. The
content for both scales JAFAS and the JAFAR was derived
from the HAQ, AIMS, and the McMaster Health Index
Questionnaire [57]. The greatest limiting feature for both
scales is that they cannot be used in children under 7 years
of age. Additionally, JAFAS requires a skilled trained pro-
fessional for test administration.
Juvenile Arthritis Functional Status Index (JASI)
Juvenile Arthritis Functional Status Index (JASI) evaluates
activities of daily living and functional mobility in chil-
dren with JIA between 8–18 years of age [12,13]. Items for
JASI were generated rigorously after interviews of chil-
dren, parents, teachers, clinicians, and subsequently con-
solidated on priority basis. JASI part I is composed of 100
functional items divided into 5 groups that include self-
care, domestic, mobility, school, and extracurricular.
Responses are in the form of 7 point rating Likert scale.
JASI Part II is more patient-specific, where the child delin-
eates up to five tasks that are difficult to perform and these
are assessed on subsequent follow-up on an individual-
ized basis. The JASI has excellent reliability and construct
validity, but its responsiveness has not been established.
Despite good measurement properties, its use is limited
because of the longer time taken to administer the test
(over 40 minutes) and the lack of validity in children less
than 8 years of age.
Juvenile Arthritis Functionality Scale (JAFS)
The Juvenile Arthritis Functionality Scale (JAFS), a new
short is a 15-item questionnaire of physical function in
children with juvenile idiopathic arthritis (JIA), explores
physical function in 3 body areas (lower limbs, hand/
wrist, and upper segment). Validation of the Italian ver-
sion of this scale was carried out by evaluating 211 chil-
dren with JIA. The JAFS was found to be reliable,
internally consistent (Cronbach's alpha = 0.82), valid,
responsive (standardized response mean = 0.42 to 0.56),
and have discriminative ability [58].
Juvenile Arthritis Foot disability Index (JAFI)
The juvenile arthritis foot disability index (JAFI) is a new
scale derived from the International Classification of
Functioning, Disability and Health that included 27 state-
ments classified into the following dimensions: Impair-
ment, Activity Limitation, and Participation
Restriction[59]. Thirty-six children/adolescents with JIA
and 29 healthy subjects participated. Parents and adoles-
cents were asked to comment on the content. Increasing
JAFI scores was found along with increasing joint impair-
ment scores, CHAQ scores, and self-rated foot-related par-
ticipation restriction. Children with JIA had more
prominent foot-related disability as assessed by JAFI com-
pared to healthy controls. Authors found no internal
redundancy (rs > 0.90) between items. Internal consist-
ency within each subscale was acceptable (rs > 0.50) for all
items but one. They found good test-retest reliability
(weighted kappa coefficients for the 3 JAFI dimensionsPage 6 of 11
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authors reported JAFI to be valid and reliable[59].
Child Activity Limitations Interview (CALI)
The Child Activity Limitations Interview (CALI) was
developed in order to measure functional impairment sec-
ondary to recurrent pain in school-age children and ado-
lescents, and to compare this measure to the Functional
Disability Inventory. Subjects comprised 189 children
with mean age 12.4 years, with diagnoses of headaches,
juvenile idiopathic arthritis, and sickle cell disease. Inter-
nal consistency of the CALI was excellent (alpha = 0.88,
child version; alpha = 0.95, parent version). Results
showed that CALI had good internal consistency and
moderate test-retest reliability and cross-informant relia-
bility. CALI May be useful for assessing and following the
subjective report of functional impairment in school-age
children and adolescents with recurrent and chronic pain
[60].
Childhood Arthritis Impact Measurement Scales 
(CHAIMS)
The Childhood Arthritis Impact Measurement Scales
(CHAIMS), adapted from Arthritis Impact Measurement
Scales (AIMS) used in adults, was the first disease-specific
measure developed for children with JIA [14,61]. Despite
measuring physical function and discomfort in children,
this scale is not widely used [11,14,62].
Functional Status Measure FSII (R)
The Functional Status measure FSII (R), evaluates health
status of children aged 0–16 years with chronic diseases
that predominantly affect physical function [63]. The FSII
(R) is a validated general health status measure in children
between ages of 0 to 16 with 47-item (long form) and 14-
item (short form) parent-reports. The FSII (R) addresses
the areas of eating, sleeping, play behavior and emotional
health, and has been demonstrated to have good conver-
gent validity and internal consistency.
Steinbrocker classification
Developed over 5 decades ago, the Steinbrocker classifica-
tion divides patients into four functional classes based on
their abilities to perform activities of daily living, and is
used to evaluate short- and long-term functional outcome
of patients with JIA [64]. There is a wide range of disability
included in these classes and strict delineation between
subgroups is often not possible. With the advent of newer
instruments that integrate evaluation of physical, social
and mental domains, this instrument is used less often.
Weighting of joint counts
A panel of pediatric rheumatologists designed a weighted
joint score, where weights were assigned from 1 (not very
important) to 10 (essential for key functional activities) to
each joint [65]. Weighted counts of swollen and active
and/or painful joints had greater correlation as compared
to simple counts with the physician's global assessment,
parent's assessment of overall well-being and intensity of
pain than did simple counts. Weighting increased most of
the correlations between joint counts and the CHAQ,
score and the physical component of the Child Health
Questionnaire (CHQ) [65].
Childhood Myositis Assessment Scale (CMAS)
The Childhood Myositis Assessment Scale (CMAS) has
been designed as a 14-item quantitative functional assess-
ment tool used for evaluating axial and proximal muscle
function in the context of strength and endurance in chil-
dren with idiopathic inflammatory myopathies [56,66].
Takken et al found that CMAS, CHAQ and CHQ corre-
lated with muscle strength and maximal oxygen con-
sumption [67].
Other scales that measure health status and 
QOL
The following scales do not solely assess physical function
but measure health status and QOL. We have mentioned
these scales briefly in this review because physical func-
tion is measured as an important domain of the health
status, QOL and HRQOL.
Juvenile Arthritis Quality of Life Questionnaire (JAQQ)
The Juvenile Arthritis Quality of Life Questionnaire
(JAQQ) was developed as a valid and responsive disease-
specific measure of physical and psychosocial function in
children afflicted with JIA, including spondyloarthropa-
thies [9,68-71]. Children and their parents completed a
questionnaire addressing physical and psychosocial func-
tion, and general symptoms and rated items based on the
frequency of occurrence and importance. This method of
item-generation ensured content relevance. Subsequently,
the experts rated these items for their potential respon-
siveness and grouped them into four categories including
gross motor function, fine motor function, psychosocial
function and general symptoms. JAQQ was successfully
used to measure HRQOL in adolescents with JIA in UK,
but authors concluded that developmentally appropriate
issues should be included [22].
Childhood Arthritis Health Profile (CAHP)
The Childhood Arthritis Health Profile (CAHP) was
developed to evaluate the global physical and psychoso-
cial health status of children over 13 years with JIA. It is a
parent-report comprising the following domains: physical
functional status, psychosocial functioning, behavior,
general health perceptions, and family functioning and
impact of disease [72,73]. This scale consists of the CHQ
as the core general health status measure and additionally
consists of a module focused on juvenile arthritis [74,75].Page 7 of 11
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tis, but due to lack of sufficient studies published using
the CAHP, lack of parallel child-report, and inapplicabil-
ity in children under 13 years of age limits its use.
Short-Form General Health Survey SF-36 and Short Form-
20 (SF-20)
The Short-Form General Health Survey SF-36 and Short
Form-20 (SF-20) are widely used health status measures
used in clinical studies of healthy and diseased adults and
older adolescents including those with SLE and other
rheumatic diseases [76-86]. Being reliable, valid and
responsive, the SF-36 consists of multi-item scales that
measure eight domains: physical functioning, role limita-
tions due to physical health and emotional problems,
bodily pain, social functioning, general mental health
covering psychological distress and well-being, vitality,
energy or fatigue, and general health perceptions
[77,78,87]. The major limitation of studies using SF-36 or
SF-20 is that they claim to be measuring QOL when they
are actually using an instrument derived to measure
health status. Therefore a cautious review of studies using
these instruments is critical.
Child Health Questionnaire (CHQ)
The Child Health Questionnaire (CHQ), adapted form
the SF-36, evaluates the child's overall health status
through following domains: general health perceptions,
physical functioning, general behavior, mental health,
emotional or time impact, on the parent, family cohesion,
change in health, bodily pain, limitations in school, work,
and activities with friends due to physical problems and
due to emotional and behavioral difficulties, behavior,
mental health, and self-esteem, and limitations in family
activities [74]. There are both parent-(above 5 years) and
child-reports (above 10 years), but the reports are not par-
allel. The CHQ has been found to be sensitive to clinical
changes in children with JIA [88].
Pediatric QOL Inventory (PedsQL)
The Pediatric QOL Inventory (PedsQL) 4.0 generic mod-
ule is a brief, valid and reliable measure of QOL in healthy
and sick children between 2–18 years [27,89-91].
PedsQL4.0 has both parent- and child-reports with sepa-
rate language-adjusted formats for the various age-groups
[27]. Both versions comprise of 23 items that address the
following four domains: physical, emotional, social, and
school functioning. The total, physical and psychosocial
summary scores (average of emotional, social and school
functioning scores) are calculated on a 0–100 scale, with
higher score indicating better QOL. Varni et al showed
that the PedsQL appeared to influence clinical decision-
making leading to increases in HRQOL in rheumatology
clinic, and was sensitive to changes in clinical status over
time in the orthopedic clinic [92]. The PedsQL Rheuma-
tology module, designed similar to the generic module
has 22 items grouped into five domains of pain and hurt,
daily activities, treatment, worry, and communication.
Together the generic and rheumatologic modules take
about 10–15 minutes to complete and have shown to be
reliable, valid, and responsive in pediatric rheumatic dis-
eases.
The Child Health and Illness Profile, largely used for ado-
lescent research, is a valid and reliable general health sta-
tus measure for children between ages 11 and 17 years
[93-98]. The EuroQOL, a generic health utility index
extensively used in adult studies, has been shown to have
validity in assessing QOL in children with JIA [99]. The
TNO AZL Children's Quality of Life questionnaire (TAC-
QOL) is a generic parent- report of HRQOL in children
aged 6–15 years [29]. The Quality of My Life Visual Ana-
log Scale has been used for measuring the overall QOL
and HRQOL in children [4]. The Simple Measure of
Impact of Lupus Erythematosus in Youngsters© (SMI-
LEY©), a valid and reliable brief questionnaire with paral-
lel child and parent versions was developed specifically to
measure HRQOL in children with SLE [100].
Conclusion
Physical ability remains very important in children for the
development of their motor skills, self-esteem and inde-
pendence. Therefore, further refinement of existing instru-
ments, and the examination of their relationship with
cognitive skills, self-esteem and other markers of develop-
ment would contribute to a greater understanding of the
impact of physical disability in this population.
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